CMB International Investment Management Limited - Net Worth and Insider Trading
CMB International Investment Management Limited Net Worth
The estimated net worth of CMB International Investment Management Limited is at least $422 Million dollars as of 2025-06-11. CMB International Investment Management Limited is the 2201 Interest of corporation controlled by you of Biocytogen Pharmaceuticals (Beijing) Co Ltd and owns about 21,318,044 shares of Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) stock worth over $422 Million. Details can be seen in CMB International Investment Management Limited's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that CMB International Investment Management Limited has not made any transactions after 2025-04-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of CMB International Investment Management Limited
CMB International Investment Management Limited Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, CMB International Investment Management Limited owns 1 companies in total, including Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) .
Insider Ownership Summary of CMB International Investment Management Limited
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:02315 | Biocytogen Pharmaceuticals (Beijing) Co Ltd | 2025-05-07 | 2201 Interest of corporation controlled by you |
CMB International Investment Management Limited Latest Holdings Summary
CMB International Investment Management Limited currently owns a total of 1 stock. CMB International Investment Management Limited owns 21,318,044 shares of Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) as of April 30, 2025, with a value of $422 Million.
Latest Holdings of CMB International Investment Management Limited
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:02315 | Biocytogen Pharmaceuticals (Beijing) Co Ltd | 2025-04-30 | 21,318,044 | 19.80 | 422,097,271 |
Holding Weightings of CMB International Investment Management Limited
CMB International Investment Management Limited Form 4 Trading Tracker
According to the SEC Form 4 filings, CMB International Investment Management Limited has made a total of 2 transactions in Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Biocytogen Pharmaceuticals (Beijing) Co Ltd is the sale of 4,770,436 shares on April 30, 2025, which brought CMB International Investment Management Limited around $0.
Insider Trading History of CMB International Investment Management Limited
- 1
CMB International Investment Management Limited Trading Performance
CMB International Investment Management Limited Ownership Network
Ownership Network List of CMB International Investment Management Limited
Ownership Network Relation of CMB International Investment Management Limited
CMB International Investment Management Limited Owned Company Details
What does Biocytogen Pharmaceuticals (Beijing) Co Ltd do?
Who are the key executives at Biocytogen Pharmaceuticals (Beijing) Co Ltd?
CMB International Investment Management Limited is the 2201 Interest of corporation controlled by you of Biocytogen Pharmaceuticals (Beijing) Co Ltd. Other key executives at Biocytogen Pharmaceuticals (Beijing) Co Ltd include 2201 Interest of corporation controlled by you Prowell Ventures Pte Ltd , 2102 Investment manager GIC Special Investments Private Limited , and 2201 Interest of corporation controlled by you GIC Private Limited .
Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) Insider Trades Summary
Over the past 18 months, CMB International Investment Management Limited made 1 insider transaction in Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) with a net sale of 4,770,436. Other recent insider transactions involving Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) include a net sale of 4,770,436 shares made by CMB International Private Investment Limited , a net sale of 4,770,436 shares made by zhao shang yin xing gu fen you xian gong si , and a net sale of 4,770,436 shares made by zhao yin guo ji jin rong you xian gong si .
In summary, during the past 3 months, insiders sold 33,955,552 shares of Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) in total and bought 0 shares, with a net sale of 33,955,552 shares. During the past 18 months, 33,955,552 shares of Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) were sold and 1,000,000 shares were bought by its insiders, resulting in a net sale of 32,955,552 shares.
Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biocytogen Pharmaceuticals (Beijing) Co Ltd Insider Transactions
CMB International Investment Management Limited Mailing Address
Above is the net worth, insider trading, and ownership report for CMB International Investment Management Limited. Currently GuruFocus does not have mailing address information for CMB International Investment Management Limited.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
